Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, (eds) Global Burden of Disease and Risk Factors. World Bank, 2006.
Murray CJL, Lopez AD. The Global Burden of Disease: A Comparative Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020, vol 1. Harvard University Press, 1996.
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation
2007; 116: 148–304.
Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined – a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol
2000; 36: 959–69.
Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980–1990: the effect of secular trends in risk factors and treatment. JAMA
1997; 277: 535–42.
Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med
1999; 341: 1359–67.
Morris RW, Whincup PH, Papacosta O, Walker M, Thomson A. Inequalities in coronary revascularisation during the 1990s: evidence from the British regional heart study. Heart
2005; 91: 635–40.
Rasmussen JN, Rasmussen S, Gislason GH, Abildstrom SZ, Schramm TK, Torp-Pedersen C, et al. Persistent socio-economic differences in revascularization after acute myocardial infarction despite a universal health care system – a Danish study. Cardiovasc Drugs Ther
2007; 21: 449–57.
Sekhri N, Timmis A, Chen R, Junghans C, Walsh N, Zaman MJ, et al. Inequity of access to investigation and effect on clinical outcomes: prognostic study of coronary angiography for suspected stable angina pectoris. BMJ
2008; 336: 1058–61.
Rosvall M, Chaix B, Lynch J, Lindström M, Merlo J. The association between socioeconomic position, use of revascularization procedures and five-year survival after recovery from acute myocardial infarction. BMC Public Health
2008; 8: 44.
Quatromoni J, Jones R. Inequalities in socio-economic status and invasive procedures for coronary heart disease: a comparison between the USA and the UK. Int J Clin Pract
2008; 62: 1910–9.
Mitchell AJ, Malone D, Carney Doebbeling C. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry
2009; 194: 491–9.
Lord OL, Malone D, Mitchell AJ. Quality of preventive care for people with and without comorbid mental illness systematic review of comparative studies. Gen Hosp Psychiatry
2010; 32: 519–43.
Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, Lambert M, Leucht S, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry
2008; 69: 514–9.
Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J
2005; 150: 1115–21.
Unützer J, Schoenbaum M, Druss BG, Katon WJ. Transforming mental health care at the interface with general medicine: report for the President's Commission. Psychiatr Serv
2006; 57: 37–47.
De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry
2009; 24: 412–24.
National Institute for Health and Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (update). NICE, 2009 (http://www.nice.org.uk/Guidance/CG/WaveR/26).
Sáiz Ruiz J, Bobes García J, Vallejo Ruiloba J, Giner Ubago J, García-Portilla González MP, et al. Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry. Actas Esp Psiquiatr
2008; 36: 251–64.
Suvisaari JM, Saarni SI, Perälä J, Suvisaari JVJ, Härkänen T, Lönnqvist J, et al. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry
2007; 68: 1045–55.
McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res
2005; 80: 19–32.
Filik R, Sipos A, Kehoe PG, Burns T, Cooper SJ, Stevens H, et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand
2006; 113: 298–305.
Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry
2004; 65 (suppl 7): 4–18.
Sundquist K, Li X. Alcohol abuse partly mediates the association between coronary heart disease and affective or psychotic disorders: a follow-up study in Sweden. Acta Psychiatr Scand
2006; 113: 283–9.
Kilbourne AM, Cornelius JR, Han X, Haas GL, Salloum I, Conigliaro J, et al. General-medical conditions in older patients with serious mental illness. Am J Geriatr Psychiatry
2005; 13: 250–4.
Suvisaari J, Jonna Perälä J, Saarni SI, Kattainen A, Lönnqvist J, Reunanen A. Coronary heart disease and cardiac conduction abnormalities in persons with psychotic disorders in a general population. Psychiatry Res
2010; 175: 126–32.
Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry
2007; 64: 242–9.
Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry
2007; 68: 899–907.
McDermott S, Moran R, Platt T, Isaac T, Wood H, Dasari S. Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Commun Ment Health J
2005; 41: 747–55.
Curkendall SM, Mo J, Glasser DB, Stang MR, Jones JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry
2004; 65: 715–20.
De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res
2005; 76: 135–57.
Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry
1999; 60: 215–20.
Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry
2003; 64: 575–9.
Daumit GL, Goldberg RW, Anthony C, Dickerson F, Brown CH, Kreyenbuhl J, et al. Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis
2005; 193: 641–6.
Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res
2005; 80: 45–53.
Osborn DPJ, Wright CA, Levy G, King MB, Deo R, Nazareth I. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and meta-analysis. BMC Psychiatry
2008; 8: 84.
Grundy SM, Pasternak R, Greenland P, Smith S, Fuster R. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation
1999; 100: 1481–92.
Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry
1997; 171: 502–8.
Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
Arch Gen Psychiatry
2007; 64: 1123–31.
Moher DM, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ
2009; 339: 2535.
Lawrence DM, Holman CDJ, Jablensky AV, Hobbs MST. Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998. Br J Psychiatry
2003; 182: 31–6.
Zhang JM, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA
1998; 280: 1690–1.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics
1994; 50: 1088–101.
Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA
2000; 283: 506–11.
Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry
2001; 58: 565–72.
Young J, Foster D. Cardiovascular procedures in patients with mental disorders. JAMA
2000; 283: 3198–9.
Petersen LA, Normand SL, Druss BG, Rosenheck RA. Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities?
Health Serv Res
2003; 38: 41–63.
Kisely S, Smith M, Lawrence D, Cox M, Campbell LA, Maaten S. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ
2007; 176: 779–84.
Plomondon ME, Ho PM, Wang L, Greiner GT, Shore JH, Sakai JT, et al. Severe mental illness and mortality of hospitalized ACS patients in the VHA. BMC Health Serv Res
2007; 7: 146.
Jones LE, Carney CP. Mental disorders and revascularisation procedures in a commercially insured sample. Psychosom Med
2005; 67: 568–76.
Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB. Somatic hospital contacts, invasive cardiac procedures and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry
2009; 66: 713–20.
Abrams TE, Vaughan-Sarrazin M, Rosenthal GE. Psychiatric comorbidity and mortality after acute myocardial infarction. Circ Cardiovasc Qual Outcomes
2009; 2: 213–20.
Blecker S, Zhang Y, Ford DE, Guallar E, Dosreis S, Steinwachs DM, et al. Quality of care for heart failure among disabled Medicaid recipients with and without severe mental illness. Gen Hosp Psychiatry
2010; 32: 255–61.
Van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med
2004; 66: 814–22.
Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J
2006; 27: 2763–74.
Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry
1991; 36: 239–45.
Brown S, Barraclough B, Inskip H. Causes of the excess mortality of schizophrenia. Br J Psychiatry
2000; 177: 212–7.
Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophr Res
2000; 45: 21–8.
Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry
2001; 179: 498–502.
Heilä H, Haukka J, Suvisaari J, Lönnqvist J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med
2005; 35: 725–32.
Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med
2004; 164: 943–8.
Elming H, Brendorp B, Kober L, Sahebzadah N, Torp-Petersen C. QTc interval in the assessment of cardiac risk. Cardiac Electrophysiol Rev
2002; 6: 289–94.
Bär K-J, Koschke M, Boettger MK, Berger S, Kabisch A, Sauer H, et al. Acute psychosis leads to increased QT variability in patients suffering from schizophrenia. Schizophr Res
2007; 95: 115–23.
Mujica-Parodi LR, Yeragani V, Malaspina D. Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology
2005; 51: 10–5.
Jindal RD, Keshavan MS, Eklund K, Stevens A, Montrose DM, Yeragani VK. Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophr Res
2009; 113: 176–80.
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA
2002; 288: 2709–16.
Ray KK, Rao S, Seshasai K, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet
2009; 373: 1765–72.
Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med
2009; 360: 225–35.
Mitchell AJ. Do antipsychotics cost lives or save lives? Risks versus benefits from large epidemiological studies. J Clin Psychopharmacol
2009; 29: 517–9.
Crone D, Johnston LH, Gidlow C, Henley C, James DV. Uptake and participation in physical activity referral schemes in the UK: an investigation of patients referred with mental health problems. Issues Ment Health Nurs
2008; 29: 1088–97.
Li Y, Glance LG, Cai X, Mukamel DB. Are patients with coexisting mental disorders more likely to receive CABG surgery from low-quality cardiac surgeons? The experience in New York State. Med Care
2007; 45: 587–93.
Copeland LA, Zeber JE, Wang CP, Henley C, James DV, et al. Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Serv Res
2009; 9: 127.
Desai M, Rosenheck RA, Druss BG, Perlin JB. Mental disorders and quality of diabetes care in the veterans health administration. Am J Psychiatry
2002; 159: 1584–90.
Mateen FJ, Jatoi A, Lineberry TW, Aranguren D, Creagan ET, Croghan GA, et al. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology
2008; 17: 721–5.
Roberts L, Roalfe A, Wilson S, Lester H. Physical health care of patients with schizophrenia in primary care: a comparative study. Fam Pract
2007; 24: 34–40.
Vahia IV, Diwan S, Bankole AO, Kehn M, Nurhussein M, Ramirez P, et al. Adequacy of medical treatment among older persons with schizophrenia. Psychiatr Serv
2008; 59: 853–9.
Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res
2006; 86: 15–22.
Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of medicaid claims data. J Clin Psychiatry
2008; 69: 316–22.
Al-Mandhari AS, Hassan AA, Haran D. Association between perceived health status and satisfaction with quality of care: evidence from users of primary health care in Oman. Fam Pract
2004; 21: 519–27.
Kilbourne AM, McCarthy JF, Welsh D, Blow F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis
2006; 194: 598–602.
Koranyi E. Morbidity and rate of undiagnosed physical illness in a psychiatric population. Arch Gen Psychiatry
1979; 36: 414–9.
Farmer S. Medical problems of chronic patients in a community support program. Psychiatr Serv
1987; 38: 745–9.
Fallow S, Bowler C, Dennis M, Jones P. Undetected physical illness in older referrals to a community mental-health-service. Int J Geriatr Psychiatry
1995; 10: 74–5.
Bernardo M, Banegas JR, Canas F, Casademot X, Riesgo Y, Varela C. Low level of medical recognition and treatment of cardiovascular risk factors in patients with schizophrenia in Spain. 13th Biennial Winter Workshop on Schizophrenia Research. Schizophr Res
2006; 81: 176–7.
American Diabetes Association. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care
2004; 27: 596–601.
Cohn TA, Sernyak MJ. Metabolic monitoring for patients treated with antipsychotic medications. Can J Psychiatry
2006; 51: 492–501.
De Hert M, van Eyck D, De Nayer A. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. Int Clin Psychopharmacol
2006; 21 (suppl 2): 11–5.
Waterreus AJ, Laugharne JD. Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm. Med J Aust
2009; 190: 185–9.
Citrome L, Yeomans D. Do guidelines for severe mental illness promote physical health and well-being?
2005; 19: 102–9.
Buckley PF, Miller DD, Singer B. Clinicians' recognition of the metabolic adverse effects of antipsychotic medications. Schizophr Res
2005; 79: 281–8.
Haupt DW, Rosenblatt LC, Kim E, Baker RA, Whitehead R, Newcomer JW. Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. Am J Psychiatry
2009; 166: 345–53.
Schneiderhan ME, Batscha CL, Rosen C. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy
2009; 29: 975–87.
Mackin P, Bishop D, Watkinson H. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry
2007; 7: 28.
Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA. Effect size estimates of lifestyle and dietary changes on all cause mortality in coronary artery disease patients: a systematic review. Circulation
2005; 112: 924–34.
Khazaal Y, Fresard E, Rabia S, Chatton A, Rothen S, Pomini V, et al. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res
2007; 91: 169–77.
Pendlebury J, Haddad P, Dursun S. Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results. Hum Psychopharmacol
2005; 20: 447–8.
Alvarez-Jimenez M, Gonzalez-Blanch C, Vazquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, et al. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial. J Clin Psychiatry
2006; 67: 1253–60.
Weber M, Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res
2006; 83: 95–101.
Ganguli R. Behavioral therapy for weight loss in patients with schizophrenia. J Clin Psychiatry
2007; 68 (suppl 4): 19–25.
Horvitz-Lennon M, Kilbourne AM, Pincus HA. From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. Health Affairs
2006; 25: 659–69.
Dombrovski A, Rosenstock J. Bridging general medicine and psychiatry: providing general medical and preventive care for the severely mentally ill. Curr Opin Psychiatry
2004; 17: 523–9.